You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-CD40

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Carcinoma, Squamous Cell, Head and Neck Tumor, Cervical Tumor Trial in Southampton (BNT113)

Recruiting
  • Carcinoma, Squamous Cell
  • +3 more
  • Southampton, Hampshire, United Kingdom
    Univeristy Hospitals Southampton NHS Foundation Trust
May 17, 2022

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Non Small Cell Lung Cancer, Lung Cancer Trial in Bronx (drug, biological, radiation)

Recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • FLT3 Ligand (CDX-301)
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jul 18, 2022

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Cancer, Solid Tumor, Cancer of Skin Trial in New York (2141 V-11)

Recruiting
  • Cancer
  • +2 more
  • 2141 V-11
  • New York, New York
    Rockefeller University
Mar 15, 2022

Liver Transplant Rejection Trial in Worldwide (CFZ533, Tacrolimus - MMF - corticosteroids)

Active, not recruiting
  • Liver Transplant Rejection
  • CFZ533
  • Tacrolimus - MMF - corticosteroids
  • Los Angeles, California
  • +28 more
Jan 17, 2023

Cancer Trial in Houston (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Houston, Texas
    MD Anderson Cancer Center
Apr 4, 2022

Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)

Recruiting
  • Epithelial Tumor
  • Metastatic Cancer
  • NG-350A plus Pembrolizumab
  • Santa Monica, California
  • +3 more
May 4, 2022

Colorectal Tumors Trial in Portland (MEDI6469)

Terminated
  • Colorectal Neoplasms
  • Portland, Oregon
    Portland Providence Medical Center
Jan 31, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in France (Selicrelumab, Atezolizumab)

Terminated
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Créteil, France
  • +4 more
Jul 23, 2021

Non-muscle Invasive Bladder Cancer Trial in United States (2141-V11)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • Basking Ridge, New Jersey
  • +6 more
Dec 7, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Locally Advanced Rectal Adenocarcinoma Trial in United States (APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and

Recruiting
  • Locally Advanced Rectal Adenocarcinoma
  • APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days
  • mFOLFOX and Radiation Therapy 5Gy x 5 days
  • Winston-Salem, North Carolina
  • +2 more
Sep 14, 2021

Solid Tumors Trial in Worldwide (RO7300490, Atezolizumab)

Recruiting
  • Solid Tumors
  • København Ø, Denmark
  • +10 more
Jan 31, 2023

Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

Not yet recruiting
  • Nephrotic Syndrome
  • Genova, Italy
    IRCCS G. Gaslini
Jan 19, 2023

Kidney Transplantation Trial in Worldwide (CFZ533, Tacrolimus (Tac), Mycophenolate mofetil (MMF))

Completed
Has Results
  • Kidney Transplantation
  • CFZ533
  • +4 more
  • Aurora, Colorado
  • +13 more
Sep 24, 2021

Kidney Transplant Rejection Trial in Worldwide (CFZ533 - MMF - CS, Tacrolimus - MMF - +/- corticosteroids)

Completed
  • Kidney Transplant Rejection
  • CFZ533 - MMF - CS
  • Tacrolimus - MMF - +/- corticosteroids
  • Los Angeles, California
  • +73 more
Jun 8, 2022

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Antiphospholipid Syndrome
  • Thrombocytopenia
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • odetiglucan
  • CDX-1140
  • (no location specified)
Jul 29, 2022

Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

Recruiting
  • Metastatic Pancreatic Cancer
  • MesoPher
  • Mitazalimab
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Dec 6, 2022